- Global Pharma News & Resources

Psychedelic Drugs Market Size Forecast 2021-2028 Made Available by Top Research Firm

The large scale Psychedelic Drugs Market analysis report contains a comprehensive overview of definitions, scope, application, production, and CAGR (%) comparison, segmentation by type, share, revenue status, and outlook, capacity, consumption, market drivers, production status, and outlook and opportunities, export, import, emerging markets/countries growth rate. The report gives a holistic overview of the growth and other aspects of the industry in vital countries (regions). The market drivers and restraints have been thoroughly explained in this market report using SWOT analysis. Analysis and discussion of important industry trends, market size, market share estimates are also covered in the global Psychedelic Drugs Market research report.

Psychedelic Drugs Market is growing with factors such as increases prevalence of depression and mental disorders, increased research activities in the field of psychedelic medicine and increased treatment options for people suffering from depression and mental disorder. However, regulations imposed on psychedelic drugs may obstruct the growth of the market in the given forecast period.

Global Psychedelic Drugs Market Scenario                             

According to Data Bridge Market Research, the market for psychedelic drugs in Europe region has the highest market share. Market leader is Jazz Pharmaceutical, Inc. and Janssen Pharmaceuticals, Inc. which accounts an estimated market share of approximately 59.60% and 20.28%. The company has gained outstanding sale through providing products that are used in psychedelic treatment.

  • In January 2020, Jazz Pharmaceuticals, Inc., presented a new drug application (NDA) for JZP-258, a novel product of Oxybet, which has 1000 to 1500 mg less sodium than Xyrem and is highly used with narcolepsy and cataplexy. Kindness is used to treat sleep. This submission will increase the company’s footprint in the U.S. market as it is a novel product and will increase revenue if approved.

Trends Impacting the Market

Now the question is which other regions Jazz Pharmaceutical, Inc., Janssen Pharmaceuticals, and Pfizer Inc. Inc. are targeting? Data Bridge Market Research has estimated a large growth in Europe psychedelic drugs market and the market leaders targeting Germany, France, and U.K. to be their next revenue pockets for 2021.

The psychedelic drugs market is becoming more competitive with companies such as Jazz Pharmaceutical, Inc., Janssen Pharmaceuticals, and Pfizer Inc. Inc. as they are the top dominating companies in psychedelic drugs having maximum number of products for treatment of psychedelic disorders. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global psychedelic drugs market.

For more analysis on the global psychedelic drugs market request for a briefing with our analysts

Global Psychedelic Drugs Market Development

  • In January 2020, Jazz Pharmaceuticals, Inc. has received the marketing authorization of solriamfetol (Sunosi) indicated for treatment of excessive daytime sleepiness in adults with narcolepsy. This authorization allowed the company to enhance product distribution network and to generate more revenue in the market.

Scope of the Global Psychedelic Drugs Market

The psychedelic drugs market is segmented into five regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The regions are further segmented into U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Belgium, Lithuania, Rest of Europe, Saudi Arabia, UAE, Israel and Egypt.

  • All country-based analysis of global psychedelic drugs market is further analyzed based on further segmentation. On the basis of source, the psychedelic drugs market is segmented into synthetic and natural. On the basis of type, the psychedelic drugs market is segmented into dissociatives, empathogens and others. On the basis of drugs, the psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others. On the basis of application, the psychedelic drugs market is segmented into narcolepsy, treatment resistant depression, post-traumatic stress disorder, major depressive disorder, opiate addiction and others. On the basis of route of administration, the psychedelic drugs market is segmented into oral, inhalation and injectable. On the basis of end user, the psychedelic drugs market is segmented into hospitals, specialty clinics, homecare and others. On the basis of distribution channel, the psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy.

To know more about the study

Key Pointers Covered in Global Psychedelic Drugs Market and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

  • Jazz Pharmaceuticals, Inc.
  • Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
  • Pfizer Inc.
  • Verrian
  • Avadel
  • Celon Pharma S.A.
  • F. Hoffmann-La Roche Ltd
  • Hikma Pharmaceuticals PLC
  • NeuroRx, Inc.
  • PharmaTher Inc.

Above are the key players covered in the report, to know about more and exhaustive list of psychedelic drugs market companies’, contact us

Research Methodology: Global Psychedelic Drugs Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Chief Level Officers, Product and Marketing Manager, Distributors, Buyers.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Report:

U.S. Psychedelic Drugs Market – Industry Trends and Forecast to 2027
Europe Psychedelic Drugs Market – Industry Trends and Forecast to 2028
North America Psychedelic Drugs Market – Industry Trends and Forecast to 2028
Middle East and Africa Psychedelic Drugs Market – Industry Trends and Forecast to 2028

About Data Bridge Market Research

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Data Bridge is adept at creating satisfied clients who rely on our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Editor Details

  • Company:
    • The Wire Times
Last Updated: 17-Sep-2021